Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system

Infection and Immunity

Volumn 80, Issue 2, 2012, Pages 798-814

  Juárez Rodríguez, María Dolores ^a   Arteaga Cortés, Lourdes T ^a   Kader, Rebin ^a   Curtiss III, Roy ^a,b   Clark Curtiss, Josephine E ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BCG VACCINE; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; HYBRID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; LIVE VACCINE; SALMONELLOSIS VACCINE; TUMOR NECROSIS FACTOR ALPHA;

AEROSOL; AMINO TERMINAL SEQUENCE; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN FUNCTION; ARTICLE; BACTERIAL LOAD; CELL CULTURE; CHIMERA; CODON; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; CYTOSOL; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION SYSTEM; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; INTESTINE EPITHELIUM CELL; LUNG; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; PROVOCATION TEST; SALMONELLA; SPLEEN; SPLEEN CELL; TYPE III SECRETION SYSTEM;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL LINE; CYTOKINES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SALMONELLA VACCINES; TUBERCULOSIS VACCINES;

EID: 84857146493     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05525-11     Document Type: Article

References (83)

1. Bald D, Koul A. 2010. Respiratory ATP synthesis: the new generation of mycobacterial drug targets? FEMS Microbiol. Lett. 308:1-7.
2. Bastos RG, Borsuk S, Seixas FK, Dellagostin OA. 2009. Recombinant Mycobacterium bovis BCG. Vaccine 27:6495-6503.
3. Behr MA, et al. 1999. Comparative genomics of BCG vaccines by wholegenome DNA microarray. Science 284:1520-1523.
4. Bertani G. 1951. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 62:293-300.
5. Berthet FX, Rasmussen PB, Rosenkrands I, Andersen P, Gicquel B. 1998. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 144:3195-3203.
6. Bochner BR. 1984. Curing bacterial cells of lysogenic viruses by using UCB indicator plates. Biotechniques 2:234-240.
7. Bollen WS, Gunn BM, Mo H, Lay MK, Curtiss R, III. 2008. Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes. Infect. Immun. 76:3268-3272.
8. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
9. Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P. 2000. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect. Immun. 68:791-795.
10. Cárdenas L, Clements JD. 1992. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin. Microbiol. Rev. 5:328-342.
11. Cardona PJ. 2010. Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease. Arch. Immunol. Ther. Exp. 58:7-14.
12. Cheminay C, Hensel M. 2008. Rational design of Salmonella recombinant vaccines. Int. J. Med. Microbiol. 298:87-98.
13. Chen LM, Briones G, Donis RO, Galán JE. 2006. Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development. Infect. Immun. 74:5826-5833.
14. Cohen SN, Miller CA. 1970. Non-chromosomal antibiotic resistance in bacteria. II. Molecular nature of R-factors isolated from Proteus mirabilis and Escherichia coli. J. Mol. Biol. 50:671-687.
15. Collazo CM, Galán JE. 1997. The invasion-associated type III system of Salmonella Typhimurium directs the translocation of Sip proteins into the host cell. Mol. Microbiol. 24:747-756.
16. Cooper AM, et al. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247.
17. Cozzarelli NR, Kelly RB, Kornberg A. 1968. A minute circular DNA from Escherichia coli 15. Proc. Natl. Acad. Sci. U. S. A. 60:992-999.
18. Curtis R, III. 1965. Chromosomal aberrations associated with mutations to bacteriophage resistance in Escherichia coli. J. Bacteriol. 89:28-40.
19. Curtiss R, III. 2002. Bacterial infectious disease control by vaccine development. J. Clin. Invest. 110:1061-1066.
20. Curtiss R, III. April 2003. Regulation of attenuation of live vaccines to enhance cross protective immunity. International patent WO 03/096812.
21. Curtiss R, III, Kelly SM. 1987. Salmonella Typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55:3035-3043.
22. Curtiss R, III, Kong W. June 2006. Regulated bacterial lysis for gene vaccine vector delivery and antigen release. US patent 2006/0140975 A1.
23. Curtiss R, III, et al. 2009. Salmonella enterica serovar Typhimurium strains with regulated delayed attenuation in vivo. Infect. Immun. 77:1071-1082.
24. Curtiss R, III, et al. 2010. New technologies in using recombinant attenuated Salmonella vaccine vectors. Crit. Rev. Immunol. 30:255-270.
25. Day JB, Ferracci F, Plano GV. 2003. Translocation of YopE and YopN into eukaryotic cells by Yersinia pestis yopN, tyeA, sycN, yscB and lcrG deletion mutants measured using a phosphorylatable peptide tag and phosphospecific antibodies. Mol. Microbiol. 47:807-823.
26. Edwards RA, Keller LH, Schifferli DM. 1998. Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207:149-157.
27. Evans DT, et al. 2003. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. J. Virol. 77:2400-2409.
28. +, T cells in the lungs following aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 67:3242-3247.
29. Fine PE. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339-1345.
30. Flynn JL, et al. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
31. Foster JW, Bearson B. 1994. Acid-sensitive mutants of Salmonella Typhimurium identified through a dinitrophenol lethal screening strategy. J. Bacteriol. 176:2596-2602.
32. Galán JE, Curtiss R, III. 1990. Expression of Salmonella typhimurium genes required for invasion is regulated by changes in DNA supercoiling. Infect. Immun. 58:1879-1885.
33. Galán JE, Ginocchio C, Costeas P. 1992. Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family. J. Bacteriol. 174:4338-4349.
34. Galán JE, Collmer A. 1999. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284:1322-1328.
35. Germanier R, Fürer E. 1971. Immunity in experimental Salmonellosis. II. Basis for the avirulence and protective capacity of galE mutants of Salmonella Typhimurium. Infect. Immun. 4:663-673.
36. Getahun A, Dahlström J, Wernersson S, Heyman B. 2004. IgG2amediated enhancement of antibody and T cell responses and its relation to inhibitory and activating Fc gamma receptors. J. Immunol. 172:5269-5276.
37. BAD promoter. J. Bacteriol. 177:4121-4130.
38. Hall LJ, et al. 2009. Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein. Vaccine 27:6894-6904.
39. Hardt WD, Chen LM, Schuebel KE, Bustelo XR, Galán JE. 1998. Salmonella Typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93:815-826.
40. Hardt WD, Urlaub H, Galán JE. 1998. A substrate of the centisome 63 type III protein secretion system of Salmonella Typhimurium is encoded by a cryptic bacteriophage. Proc. Natl. Acad. Sci. U. S. A. 95:2574-2579.
41. Hess J, et al. 2000. Protection against murine tuberculosis by an attenuated recombinant Salmonella Typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG. FEMS Immunol. Med. Microbiol. 27:283-289.
42. Jenson AB, Jenson MC, Cowsert L, Ghim SJ, Sundberg JP. 1997. Multiplicity of uses of monoclonal antibodies that define papillomavirus linear immunodominant epitopes. Immunol. Res. 16:115-119.
43. Juárez-Rodríguez MD, Clark-Curtiss J, Torres-Escobar A, Curtiss R, III. 2007. Development of recombinant attenuated Salmonella vaccine (RASV) to deliverMycobacterium tuberculosis ESAT-6-CFP10 antigens by the type III secretion system, abstr D-091, p 113. Abstr. 107th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
44. Kang HY, Dozois CM, Tinge SA, Lee TH, Curtiss R, III. 2002. Transduction-mediated transfer of unmarked deletion and point mutations through use of counterselectable suicide vectors. J. Bacteriol. 184:307-312.
45. Kang HY, Srinivasan J, Curtiss R, III. 2002. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect. Immun. 70:1739-1749.
46. Karavolos MH, et al. 2005. Type III secretion of the Salmonella effector protein SopE is mediated via an N-terminal amino acid signal and not an mRNA sequence. J. Bacteriol. 187:1559-1567. (Erratum, 187:5505.)
47. Kong W, et al. 2008. Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc. Natl. Acad. Sci. U. S. A. 105:9361-9366.
48. Konjufca V, Jenkins M, Wang S, Juarez-Rodriguez MD, Curtiss R, III. 2008. Immunogenicity of recombinant attenuated Salmonella enterica serovar Typhimurium vaccine strains carrying a gene that encodes Eimeria tenella antigen SO7. Infect. Immun. 76:5745-5753.
49. Kubori T, Galán JE. 2003. Temporal regulation of Salmonella virulence effector function by proteasome-dependent protein degradation. Cell 115:333-342.
50. Lee SH, Galán JE. 2003. InvB is a type III secretion-associated chaperone for the Salmonella enterica effector protein SopE. J. Bacteriol. 185:7279-7284.
51. Lennox ES. 1955. Transduction of linked genetic characters of the host by bacteriophage P1. Virology 1:190-206.
52. Li Y, et al. 2009. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc. Natl. Acad. Sci. U. S. A. 106:593-598.
53. Liu T, Chopra AK. 2010. An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44(high) and CD4T regulatory (T(reg)) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growth. Cancer Gene Ther. 17:97-108.
54. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. 1996. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178:1274-1282.
55. Martin RM, Lew AM. 1998. Is IgG2a a good Th1 marker in mice? Immunol. Today 19:49.
56. Matsuyama S, Inokuchi K, Mizushima S. 1984. Promoter exchange between ompF and ompC, genes for osmoregulated major outer membrane proteins of Escherichia coli K-12. J. Bacteriol. 158:1041-1047.
57. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193:271-280.
58. Mollenkopf HJ, Groine-Triebkorn D, Andersen P, Hess J, Kaufmann SH. 2001. Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella Typhimurium vaccine carrier strain and expressed by naked DNA. Vaccine 19:4028-4035.
59. Monach DM, Raupach B, Hromockyj AE, Falkow S. 1996. Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc. Natl. Acad. Sci. U. S. A. 93:9833-9838.
60. + expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Biotechnology (NY) 6:693-697.
61. Orme IM. 2006. Preclinical testing of new vaccines for tuberculosis: a comprehensive review. Vaccine 24:2-19.
62. Pathangey L, Kohler JJ, Isoda R, Brown TA. 2009. Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines. Vaccine 27:2707-2711.
63. Perez JC, et al. 2009. Evolution of a bacterial regulon controlling virulence and Mg(2+) homeostasis. PLoS Genet. 5:e1000428.
64. Rihs HP, Peters R. 1989. Nuclear transport kinetics depend on phosphorylation-site-containing sequences flanking the karyophilic signal of the Simian virus 40 T-antigen. EMBO J. 8:1479-1484.
65. Rüssmann H, et al. 1998. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281:565-568.
66. Sambrook J, Russell DW. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
67. Schmidt-Weber CB, Alexander SI, Henault LE, James L, Lichtman AH. 1999. IL-4 enhances IL-10 gene expression in murine Th2 cells in the absence of TCR engagement. J. Immunol. 162:238-244.
68. + memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope. Vaccine 20:577-585.
69. Skjøt RL, et al. 2000. Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect. Immun. 68:214-220.
70. Smith HW. 1956. The use of live vaccines in experimental Salmonella gallinarum infection in chickens with observations on their interference effect. J. Hyg. (Lond.) 54:419-432.
71. Snapper CM, Marcu KB, Zelazowski P. 1997. The immunoglobulin class switch: beyond "accessibility." Immunity 6:217-223.
72. Sørensen AL, Nagai S, Houen G, Andersen P, Andersen AB. 1995. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect. Immun. 63:1710-1717.
73. Sousa AO, et al. 1999. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci. U. S. A. 97:4204-4208.
74. Torres-Escobar A, et al. 2010. Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar Typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice. Infect. Immun. 78:2529-2543.
75. Torres-Escobar A, Juárez-Rodríguez MD, Branger CG, Curtiss R, III. 2010. Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA. Vaccine 28:5810-5816.
76. Trunz BB, Fine P, Dye C. 2006. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a metaanalysis and assessment of cost-effectiveness. Lancet 367:1173-1180.
77. Vazquez-Torres A, et al. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:804-808.
78. Wang QL, et al. 2009. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis. Vaccine 27:6712-6722.
79. Wang S, et al. 2010. Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. Infect. Immun. 78:3969-3980.
80. World Health Organization. 2010. Global tuberculosis control surveillance, planning, financing: WHO report 2010. Document WHO/HTM/TB/2010.104. World Health Organization, Geneva, Switzerland.
81. Xin W, et al. 2008. Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect. Immun. 76:3241-3254.
82. Yanisch-Perron C, Vieira J, Messing J. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.
83. Zekarias B, Mo H, Curtiss R, III. 2008. Recombinant attenuated Salmonella enterica serovar Typhimurium expressing the carboxy-terminal domain of alpha toxin from Clostridium perfringens induces protective responses against necrotic enteritis in chickens. Clin. Vaccine Immunol. 15:805-816.